FDAnews Device Daily Bulletin

J&J’s $21-Billion Synthes Acquisition Could Lead to Industry Consolidation

May 3, 2011
After weeks of speculation, Johnson & Johnson (J&J) will become the largest provider of orthopedic trauma devices with its $21.3-billion purchase of Synthes. Under terms of the deal revealed Wednesday, J&J will buy the Swiss devicemaker with a combination of cash and J&J stock. Upon completion, Synthes and J&J’s orthopedics-focused DePuy unit will be the largest business within the company’s medical devices and diagnostics segment.
Devices & Diagnostics Letter